Correlation Between Vaxcyte and NRX Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaxcyte and NRX Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and NRX Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaxcyte and NRX Pharmaceuticals, you can compare the effects of market volatilities on Vaxcyte and NRX Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of NRX Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and NRX Pharmaceuticals.

Diversification Opportunities for Vaxcyte and NRX Pharmaceuticals

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Vaxcyte and NRX is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and NRX Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRX Pharmaceuticals and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with NRX Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRX Pharmaceuticals has no effect on the direction of Vaxcyte i.e., Vaxcyte and NRX Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vaxcyte and NRX Pharmaceuticals

Given the investment horizon of 90 days Vaxcyte is expected to generate 0.44 times more return on investment than NRX Pharmaceuticals. However, Vaxcyte is 2.3 times less risky than NRX Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. NRX Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest  5,096  in Vaxcyte on August 31, 2024 and sell it today you would earn a total of  4,338  from holding Vaxcyte or generate 85.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vaxcyte  vs.  NRX Pharmaceuticals

 Performance 
       Timeline  
Vaxcyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
NRX Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NRX Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Vaxcyte and NRX Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaxcyte and NRX Pharmaceuticals

The main advantage of trading using opposite Vaxcyte and NRX Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, NRX Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will offset losses from the drop in NRX Pharmaceuticals' long position.
The idea behind Vaxcyte and NRX Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stocks Directory
Find actively traded stocks across global markets